AESGP VIEWS EURO BOOST FOR SELF-CARE

26 June 1994

The European Commission's adoption of a five-year action program aimed at encouraging the adoption of healthier lifestyles throughout the European Union is an important step towards the active promotion of responsible self-medication, according to the European Proprietary medicines Manufacturers Association (AESGP).

In a communication about the program, the Commission notes the trend towards the use of over-the-counter medicines, and says sensible self-medication may help to reduce health spending by cutting the number of consultations. However, this trend must be accompanied by a strengthening of information measures if it is not to have an adverse effect on public health. Giving people more choice and responsibility must involve ensuring that they are equipped to make sensible choices, and they must also be made aware and properly informed of the need to consult a doctor if symptoms persist or doubts exist.

Providing specially-tailored information to doctors and pharmacists about the availability of different drugs may also lead to cheaper treatment with equal results, it says, and providing sufficient information to consumers can also contribute to a more sensible use of medicines.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight